Exact Mass: 394.0236
Exact Mass Matches: 394.0236
Found 26 metabolites which its exact mass value is equals to given mass value 394.0236,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
(2RS,4RS,7SR,9aSR)-7-bromo-2-(bromomethyl)decahydro-6,6,9a-trimethyl-3-methylidene-1-benzoxepin-4-ol|4-hydroxypalisadin C
(2RS,4RS,7SR,9aSR)-7-bromo-2-(bromomethyl)decahydro-6,6,9a-trimethyl-3-methylidene-1-benzoxepin-4-ol|4-hydroxypalisadin C
1,5,5-trimethyl-3-(4-methylphenyl)sulfonyl-4H-imidazol-1-ium,iodide
1,5,5-trimethyl-3-(4-methylphenyl)sulfonyl-4H-imidazol-1-ium,iodide
1-(3-CHLOROPHENYL)-3-(1-(3,4-DICHLOROBENZYL)-1H-PYRAZOL-3-YL)UREA
1-(3-CHLOROPHENYL)-3-(1-(3,4-DICHLOROBENZYL)-1H-PYRAZOL-3-YL)UREA
2-[[1-oxo-2-(1H-1,2,4-triazol-5-ylthio)ethyl]amino]-4-thiophen-2-yl-3-thiophenecarboxylic acid ethyl ester
2-[[1-oxo-2-(1H-1,2,4-triazol-5-ylthio)ethyl]amino]-4-thiophen-2-yl-3-thiophenecarboxylic acid ethyl ester
[(2R)-2-amino-3-(carboxymethylamino)-3-oxopropyl]sulfanyl-methylmercury
[(2R)-2-amino-3-(carboxymethylamino)-3-oxopropyl]sulfanyl-methylmercury
ethyl 2-[(2-chlorophenyl)sulfanylmethyl]-5-methyl-4-oxo-3H-thieno[2,3-d]pyrimidine-6-carboxylate
ethyl 2-[(2-chlorophenyl)sulfanylmethyl]-5-methyl-4-oxo-3H-thieno[2,3-d]pyrimidine-6-carboxylate
5-[(2-Bromo-6-chlorophenyl)methyl]-1-tert-butyl-4-pyrazolo[3,4-d]pyrimidinone
5-[(2-Bromo-6-chlorophenyl)methyl]-1-tert-butyl-4-pyrazolo[3,4-d]pyrimidinone
4-[(1-Methyl-5-tetrazolyl)thio]-5-[3-(trifluoromethyl)phenyl]thieno[2,3-d]pyrimidine
4-[(1-Methyl-5-tetrazolyl)thio]-5-[3-(trifluoromethyl)phenyl]thieno[2,3-d]pyrimidine
4-[(1-Methyl-5-tetrazolyl)thio]-5-[2-(trifluoromethyl)phenyl]thieno[2,3-d]pyrimidine
4-[(1-Methyl-5-tetrazolyl)thio]-5-[2-(trifluoromethyl)phenyl]thieno[2,3-d]pyrimidine
4-[(1-Methyl-5-tetrazolyl)thio]-5-[4-(trifluoromethyl)phenyl]thieno[2,3-d]pyrimidine
4-[(1-Methyl-5-tetrazolyl)thio]-5-[4-(trifluoromethyl)phenyl]thieno[2,3-d]pyrimidine
M1002
M1002
M1002 is a hypoxia-inducible factor-2 (HIF-2) agonist, and can enhance the expression of HIF-2 target genes. M1002 shows synergy with prolyl-hydroxylase domain (PHD) inhibitors[1].
(3r,5r,6r,8s,11s)-11-bromo-6-(bromomethyl)-5,8,12,12-tetramethyl-4,7-dioxatricyclo[6.4.0.0³,⁵]dodecane
(3r,5r,6r,8s,11s)-11-bromo-6-(bromomethyl)-5,8,12,12-tetramethyl-4,7-dioxatricyclo[6.4.0.0³,⁵]dodecane
[(2r,7s,9as)-7-bromo-2-(bromomethyl)-6,6,9a-trimethyl-2,5,5a,7,8,9-hexahydro-1-benzoxepin-3-yl]methanol
[(2r,7s,9as)-7-bromo-2-(bromomethyl)-6,6,9a-trimethyl-2,5,5a,7,8,9-hexahydro-1-benzoxepin-3-yl]methanol
[(2r,5as,7s,9as)-7-bromo-2-(bromomethyl)-6,6,9a-trimethyl-2,5,5a,7,8,9-hexahydro-1-benzoxepin-3-yl]methanol
[(2r,5as,7s,9as)-7-bromo-2-(bromomethyl)-6,6,9a-trimethyl-2,5,5a,7,8,9-hexahydro-1-benzoxepin-3-yl]methanol
(2r,4r,7s,9as)-7-bromo-2-(bromomethyl)-6,6,9a-trimethyl-3-methylidene-hexahydro-2h-1-benzoxepin-4-ol
(2r,4r,7s,9as)-7-bromo-2-(bromomethyl)-6,6,9a-trimethyl-3-methylidene-hexahydro-2h-1-benzoxepin-4-ol
